These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31482299)

  • 1. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection.
    Mohanty A; Salameh S; Butt AA
    Curr HIV/AIDS Rep; 2019 Oct; 16(5):389-394. PubMed ID: 31482299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy.
    Negro F
    Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31636094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic manifestations of HCV: the role of direct acting antivirals.
    Polo ML; Laufer N
    Expert Rev Anti Infect Ther; 2017 Aug; 15(8):737-746. PubMed ID: 28696154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion of disease manifestations after HCV eradication.
    van der Meer AJ; Berenguer M
    J Hepatol; 2016 Oct; 65(1 Suppl):S95-S108. PubMed ID: 27641991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
    Ioannou GN; Feld JJ
    Gastroenterology; 2019 Jan; 156(2):446-460.e2. PubMed ID: 30367836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.
    Salama II; Raslan HM; Abdel-Latif GA; Salama SI; Sami SM; Shaaban FA; Abdelmohsen AM; Fouad WA
    World J Hepatol; 2022 Jun; 14(6):1053-1073. PubMed ID: 35978668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of hepatitis C virus outside the liver: Evidence from Asia.
    Younossi ZM; Tanaka A; Eguchi Y; Lim YS; Yu ML; Kawada N; Dan YY; Brooks-Rooney C; Negro F; Mondelli MU
    Liver Int; 2017 Feb; 37(2):159-172. PubMed ID: 27748564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
    Adinolfi LE; Rinaldi L; Nevola R
    World J Gastroenterol; 2018 Nov; 24(41):4617-4621. PubMed ID: 30416309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus Eradication with New Interferon-Free Treatment Improves Metabolic Profile in Hepatitis C Virus-Related Liver Transplant Recipients.
    Beig J; Orr D; Harrison B; Gane E
    Liver Transpl; 2018 Aug; 24(8):1031-1039. PubMed ID: 29577581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.
    Al-Khazraji A; Patel I; Saleh M; Ashraf A; Lieber J; Malik R
    Dig Dis; 2020; 38(1):46-52. PubMed ID: 31422405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
    Lam L; Fontaine H; Lapidus N; Dorival C; Bellet J; Larrey D; Nahon P; Diallo A; Cagnot C; Lusivika-Nzinga C; Téoulé F; Hejblum G; Bourlière M; Pol S; Carrat F;
    Pharmacoepidemiol Drug Saf; 2023 Apr; 32(4):486-495. PubMed ID: 36444965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials.
    Arias A; Aguilera A; Soriano V; Benítez-Gutiérrez L; Lledó G; Navarro D; Treviño A; Otero E; Peña JM; Cuervas-Mons V; de Mendoza C
    Antivir Ther; 2017; 22(4):307-312. PubMed ID: 27341294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review.
    Fehily SR; Papaluca T; Thompson AJ
    Semin Liver Dis; 2019 Jul; 39(3):341-353. PubMed ID: 31041785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters.
    Ferreira J; Bicho M; Serejo F
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.
    Béguelin C; Suter A; Bernasconi E; Fehr J; Kovari H; Bucher HC; Stoeckle M; Cavassini M; Rougemont M; Schmid P; Wandeler G; Rauch A;
    Liver Int; 2018 Mar; 38(3):424-431. PubMed ID: 28741901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From current status to optimization of HCV treatment: Recommendations from an expert panel.
    Craxì A; Perno CF; Viganò M; Ceccherini-Silberstein F; Petta S;
    Dig Liver Dis; 2016 Sep; 48(9):995-1005. PubMed ID: 27388261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrahepatic manifestations in chronic hepatitis C virus carriers.
    Rosenthal E; Cacoub P
    Lupus; 2015 Apr; 24(4-5):469-82. PubMed ID: 25801890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis.
    Petta S; Adinolfi LE; Fracanzani AL; Rini F; Caldarella R; Calvaruso V; Cammà C; Ciaccio M; Di Marco V; Grimaudo S; Licata A; Marrone A; Nevola R; Pipitone RM; Pinto A; Rinaldi L; Torres D; Tuttolomondo A; Valenti L; Fargion S; Craxì A
    J Hepatol; 2018 Jul; 69(1):18-24. PubMed ID: 29505844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of hepatitis C cure with antivirals: why test and treat?
    Lledó G; Benítez-Gutiérrez L; Arias A; Requena S; Cuervas-Mons V; de Mendoza C
    Future Microbiol; 2019 Mar; 14():425-435. PubMed ID: 30900911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.